frivolous
发表于 2025-3-25 04:20:45
http://reply.papertrans.cn/27/2682/268150/268150_21.png
nullify
发表于 2025-3-25 07:56:49
http://reply.papertrans.cn/27/2682/268150/268150_22.png
Mammal
发表于 2025-3-25 13:06:46
The Thomist-Catholic View of FaithA key objective of the drug discovery project team is to discharge as much risk as possible for the selected candidate such that the best possible molecule can be progressed.
减至最低
发表于 2025-3-25 17:24:03
The non-Objectivity of Faith and RevelationDeveloping and selecting a candidate molecule for an oral/systemic indication is not easy and the attrition rate remains high despite strong and widespread knowledge available to develop an effective risk discharge cascade to identify good candidate molecules.
烦忧
发表于 2025-3-25 23:04:49
http://reply.papertrans.cn/27/2682/268150/268150_25.png
套索
发表于 2025-3-26 00:23:23
Topical Versus Oral/Systemic Drug Discovery,Over the past decades, the drug discovery process of the pharmaceutical industry has vastly improved.
有杂色
发表于 2025-3-26 08:16:30
http://reply.papertrans.cn/27/2682/268150/268150_27.png
Emmenagogue
发表于 2025-3-26 09:20:36
http://reply.papertrans.cn/27/2682/268150/268150_28.png
龙虾
发表于 2025-3-26 16:26:55
Topical Drug Candidate Selection Criteria and Cascade,A key objective of the drug discovery project team is to discharge as much risk as possible for the selected candidate such that the best possible molecule can be progressed.
palliative-care
发表于 2025-3-26 18:41:48
Conclusions and Perspectives,Developing and selecting a candidate molecule for an oral/systemic indication is not easy and the attrition rate remains high despite strong and widespread knowledge available to develop an effective risk discharge cascade to identify good candidate molecules.